نتائج البحث

The Omission of Anthracycline Chemotherapy in Women with Early HER2-Negative Breast Cancer—A Systematic Review and Meta-Analysis.

• Authors : Giffoni de Mello Morais Mata, Danilo^1,2 (AUTHOR) ; Rush, Mary-Beth³ (AUTHOR) ; Smith-Uffen, Megan⁴ (AUTHOR)

• Source: Current Oncology. Aug2024, Vol. 31 Issue 8, p4486-4506. 21p.

تفاصيل العنوان

Phase 2 Trial of Epcoritamab in Combination With Rituximab-mini CVP for Older Unfit/Frail Patients or Anthracycline-Ineligible Adult Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma

• Source: Phase 2 Trial of Epcoritamab in Combination With Rituximab-mini CVP for Older Unfit/Frail Patients or Anthracycline-Ineligible Adult Patients With Newly Diagnosed

تفاصيل العنوان

Detection and Prevention of Anthracycline-Related Cardiac Toxicity With Concurrent Simvastatin

• Authors : Avon Foundation

• Source: Detection and Prevention of Anthracycline-Related Cardiac Toxicity With Concurrent Simvastatin

تفاصيل العنوان

Prevention of Anthracycline-Induced Cardiac Dysfunction With Dexrazoxane in Patients With Diffuse Large-B Cell Lymphoma (HO170DLBCL)

• Authors : UMC Utrecht; Amsterdam University Medical Centers; The Dutch Network for Cardiovascular Research (WCN)

• Source: ANTICIPATE: Prevention of ANThracycline-Induced Cardiac Dysfunction by Dexrazoxane In PATients With diffusE Large B-cell Lymphoma: a Phase III National Multicenter

تفاصيل العنوان

The Omission of Anthracycline Chemotherapy in Women with Early HER2-Negative Breast Cancer—A Systematic Review and Meta-Analysis

• Authors : Danilo Giffoni de Mello Morais Mata; Mary-Beth Rush; Megan Smith-Uffen

Subjects: human epidermal growth factor receptor 2 negative; endocrine (hormone) receptor; paclitaxel

• Source: Current Oncology, Vol 31, Iss 8, Pp 4486-4506 (2024)

تفاصيل العنوان

A prospective audit on the use of prophylactic antiemetics and rates of CINV in patients receiving carboplatin AUC≥4 or combination anthracycline-cyclophosphamide.

• Authors : Lo E; Phase 1/Lung Research Fellow, Auckland Cancer Trials Centre, Auckland District Health Board.; Anderson M

Subjects: Anthracyclines/Anthracyclines/Anthracyclines/*adverse effects ; Antiemetics/Antiemetics/Antiemetics/*therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*adverse effects

• Source: The New Zealand medical journal [N Z Med J] 2021 Apr 16; Vol. 134 (1533), pp. 33-45. Date of Electronic Publication: 2021 Apr 16.Publisher: Pasifika Medical Association Group Country of Publication: New Zealand NLM ID: 0401067 Publication Model: Electronic Cited Medium: Internet

تفاصيل العنوان

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

• Authors : National Cancer Institute (NCI)

• Source: Shorter Anthracycline-Free Chemo Immunotherapy Adapted to Pathological Response in Early Triple Negative Breast Cancer (SCARLET), A Randomized Phase III Study

تفاصيل العنوان

A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer (IMpassion030)

• Authors : Breast International Group; Alliance Foundation Trials (AFT); Institut Jules Bordet/Clinical Trials Support Unit (IJB/CTSU)

• Source: A Phase III, Multicenter, Randomized, Open-Label Study Comparing Atezolizumab (Anti PD-L1 Antibody) in Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy

تفاصيل العنوان

Netupitant/palonosetron (NEPA) and dexamethasone for prevention of emesis in breast cancer patients receiving adjuvant anthracycline plus cyclophosphamide: a multi-cycle, phase II study.

• Authors : Caputo R; Breast Medical Oncology Division, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Naples, Italy.; Cazzaniga ME

Subjects: Anthracyclines/Anthracyclines/Anthracyclines/*adverse effects ; Antiemetics/Antiemetics/Antiemetics/*therapeutic use ; Antineoplastic Agents, Alkylating/Antineoplastic Agents, Alkylating/Antineoplastic Agents, Alkylating/*adverse effects

• Source: BMC cancer [BMC Cancer] 2020 Mar 19; Vol. 20 (1), pp. 232. Date of Electronic Publication: 2020 Mar 19.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

تفاصيل العنوان

Evaluate the in vitro effect of anthracycline and alkylating cytophosphane chemotherapeutics on dopaminergic neurons

• Authors : Darshini Desai; Mohammed Majrashi; Suhrud Pathak

Subjects: apoptosis; cyclophosphamide; dopaminergic neurotoxicity

• Source: Cancer Reports, Vol 7, Iss 4, Pp n/a-n/a (2024)

تفاصيل العنوان